Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study

PLoS ONE - United States
doi 10.1371/journal.pone.0132514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Evaluation of Xpert MTB-RIF Guided Diagnosis and Treatment of Rifampicin-Resistant Tuberculosis in Indonesia: A Retrospective Cohort Study

PLoS ONE
Multidisciplinary
2019English

Combination of Xpert MTB/RIF and TBAg/PHA Ratio for Prompt Diagnosis of Active Tuberculosis: A Two-Center Prospective Cohort Study

Frontiers in Medicine
Medicine
2020English

Urine Xpert MTB/RIF for the Diagnosis of Childhood Tuberculosis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Diagnosis of Extrapulmonary Tuberculosis Using the Xpert®MTB/Rif Assay

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-Of-Care Test

The Lancet Infectious Diseases
Infectious Diseases
2013English

Mycobacterium Tuberculosis Detection From Oral Swabs With Xpert MTB/RIF ULTRA: A Pilot Study

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2019English

Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-Hiv-Burden Setting

Journal of Clinical Microbiology
Microbiology
2018English

Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Rapid Diagnosis of Extra Pulmonary Tuberculosis by Automated Xpert MTB/RIF Assay

BMC Infectious Diseases
Infectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy